Review of Current First-Line Pharmacotherapy Strategies for Thyroid Eye Disease
Thyroid eye disease (TED) is a challenging autoimmune disorder that often requires therapeutic intervention. Glucocorticoids (GCs), particularly in intravenous (IV) regimens, remain the first-line treatment due to their strong anti-inflammatory and immunosuppressive effects. This paper focuses on t...
Saved in:
| Main Authors: | Julia Ryniecka, Maciej Wojszczyk, Damian Zys, Piotr Pasek, Julia Kulbacka, Michalina Wójcikiewicz, Marta Chuncia-Ileczko, Julia Kacperczyk, Filip Arczewski, Karol Dziedzic |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nicolaus Copernicus University in Toruń
2025-01-01
|
| Series: | Quality in Sport |
| Subjects: | |
| Online Access: | https://apcz.umk.pl/QS/article/view/57699 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quantifying anterior segment vascular changes in thyroid eye disease using optical coherence tomography angiography
by: Ahmad Masoumi, et al.
Published: (2025-03-01) -
Efficacy of tocilizumab in resistant forms of Thyroid Eye Disease
by: Marković Bojan, et al.
Published: (2025-01-01) -
Sorozatgyilkosok nyomában: Ted Bundy
by: András László Pap
Published: (2011-11-01) -
Efficacy and safety of various Intravenous Methylprednisolone regimens in Moderate to Severe Thyroid Eye Disease: A systematic review
by: Ankita Aishwarya, et al.
Published: (2025-08-01) -
A RHETORICAL ANALYSIS OF COMMENTS AND DELIVERY STRATEGY ON TED TALKS
by: Ildi Kurniawan
Published: (2021-02-01)